Kovač, MD, PhD, Viljem, Matjaz Zwitter, Karmen Stanic, Mirjana Rajer, Izidor Kern, Martina Vrankar, and Natalija Edelbaher. 2014. “Intercalated Chemotherapy and Erlotinib for Advanced NSCLC: High Proportion of Complete Remissions and Prolonged Progression-Free Survival Among Patients With EGFR Activating Mutations”. Radiology and Oncology 48 (4). https://radioloncol.com/index.php/ro/article/view/2233.